5 new weight-loss drugs to watch in the fight for the next Ozempic
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...
Lost and found: Life after Ozempic and other weight-loss drugs was just the start for these four people
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...
MedPage Today on MSN18h
How Often Do Doctors Use New Weight-Loss Drugs in Kids?
As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...
Ozempic, Wegovy, Mounjaro: How dangerous are they?
The death of a Scottish nurse as a result of complications after taking the drug Mounjaro for weight loss has highlighted the potential dangers ...
US FDA approves Syndax's blood cancer drug
The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...
Science Daily17h
Clinical trial shows positive results for potential treatment to combat a challenging rare disease
Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).